Doctors have welcomed the news that a proven minimally invasive treatment for the most common male health condition is now widely available on the NHS.
The UroLift System is a new procedure, approved by the National Institute for Clinical Excellence, to treat benign prostatic disease in men.
UroLift is the first permanent implant to treat symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH) in men 50 years of age or older.
Marc Lucky, Consultant Urologist at Aintree (pictured), said: “It’s important that men remember that their prostate can increase in size as they get older but more often these changes are not necessarily a sign of cancer. The increasing size of the prostate can cause bothersome and worrying symptoms.
“If there are changes such as a difference in the frequency of passing urine, and how long it takes; and especially if men are getting up a lot in the night to go and it’s disturbing their sleep, we urge men to see their GP and ask to be checked to see if they need treatment.
“UroLift has an excellent safety profile and provides men suffering from an enlarged prostate a beneficial first-line treatment alternative to drug therapy or more invasive surgery. Importantly, the UroLift System provides fast and meaningful relief from BPH symptoms, improving overall quality of life for our patients without any impact on sexual function.”